+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Aimmune Therapeutics Inc (AIMT) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Aimmune Therapeutics Inc (Aimmune), formerly Allergen Research Corp is a clinical-stage biopharmaceutical company that develops proprietary product candidates for the treatment of peanut and other food allergies. The company’s lead product candidate AR101 is used to treat the peanut allergy. Its pipeline program portfolio uses characterized oral desensitization immunotherapy (CODIT), a proprietary approach to oral immunotherapy. Aimmune discovers, develops and commercializes therapies related to food allergy. The company conducts academic research in partnership with various universities and other companies to develop novel product candidates. The company operates in the US and the UK. Aimmune is headquartered in Brisbane, California, the US.

Aimmune Therapeutics Inc Key Recent Developments

Mar 04, 2018: Aimmune Therapeutics Presents Results From the Positive, Pivotal Phase 3 PALISADE Trial of AR101 for Peanut Allergy at AAAAI-WAO
Feb 14, 2018: Aimmune Therapeutics Names George du Toit and Wayne Shreffler to Scientific Advisory Board
Nov 06, 2017: Aimmune Therapeutics Announces Third Quarter 2017 Financial Results and Planned Retirement of CEO by the End of 2018
Aug 08, 2017: Aimmune Therapeutics Announces Second Quarter 2017 Financial Results
Jun 07, 2017: CoreRx and Aimmune Therapeutics Joint Expansion to Create Pharmaceutical Jobs and Increase the Base of Scientific Capabilities in the Tampa Bay Area

This comprehensive SWOT profile of Aimmune Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aimmune Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Aimmune Therapeutics Inc - Key Information
  • Aimmune Therapeutics Inc - Overview
  • Aimmune Therapeutics Inc - Key Employees
  • Aimmune Therapeutics Inc - Key Employee Biographies
  • Aimmune Therapeutics Inc - Key Operational Heads
  • Aimmune Therapeutics Inc - Major Products and Services
  • Aimmune Therapeutics Inc - History
  • Aimmune Therapeutics Inc - Company Statement
  • Aimmune Therapeutics Inc - Locations And Subsidiaries
  • Aimmune Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Aimmune Therapeutics Inc - Business Description
  • Aimmune Therapeutics Inc - Corporate Strategy
  • Aimmune Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Aimmune Therapeutics Inc - Strengths
  • Aimmune Therapeutics Inc - Weaknesses
  • Aimmune Therapeutics Inc - Opportunities
  • Aimmune Therapeutics Inc - Threats
  • Aimmune Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Aimmune Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Aimmune Therapeutics Inc, Key Information
  • Aimmune Therapeutics Inc, Key Ratios
  • Aimmune Therapeutics Inc, Share Data
  • Aimmune Therapeutics Inc, Major Products and Services
  • Aimmune Therapeutics Inc, History
  • Aimmune Therapeutics Inc, Key Employees
  • Aimmune Therapeutics Inc, Key Employee Biographies
  • Aimmune Therapeutics Inc, Key Operational Heads
  • Aimmune Therapeutics Inc, Other Locations
  • Aimmune Therapeutics Inc, Subsidiaries
  • Aimmune Therapeutics Inc, Key Manufacturing facilities
  • Aimmune Therapeutics Inc, Key Competitors
  • Aimmune Therapeutics Inc, SWOT Analysis
  • Aimmune Therapeutics Inc, Ratios based on current share price
  • Aimmune Therapeutics Inc, Annual Ratios
  • Aimmune Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Aimmune Therapeutics Inc, Performance Chart
  • Aimmune Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3


Order Online - visit: https://www.researchandmarkets.com/reports/4285213